Tu Youyou is a Chinese pharmaceutical chemist and Nobel laureate who discovered artemisinin, a life-saving antimalarial drug derived from Artemisia annua. Her work, inspired by ancient Chinese medicine texts, has saved millions of lives worldwide.
Tu Youyou was born on December 30, 1930, in Ningbo, Zhejiang Province, China. She was the only child of a well-educated family, and her early life was marked by the Japanese invasion and political turmoil. #birth #China #NobelLaureate
At age 16, Tu Youyou contracted tuberculosis, which delayed her schooling but sparked her interest in medicine. She spent two years recovering and decided to pursue a career in pharmaceuticals. #health #medicine #inspiration
Tu Youyou was admitted to the Department of Pharmacy at Peking University Medical School (now Peking University Health Science Center). She studied pharmaceutical sciences, focusing on medicinal chemistry. #education #pharmacy #China
After graduating, Tu Youyou joined the China Academy of Traditional Chinese Medicine (now China Academy of Chinese Medical Sciences) in Beijing. She began researching traditional Chinese medicine and pharmacology. #career #TCM #research
Tu Youyou attended a two-year training program in Chinese and Western medicine at the Chinese Academy of Sciences. This training helped her integrate modern scientific methods with traditional knowledge. #training #science #integration
Tu Youyou was promoted to associate researcher at the Academy of Traditional Chinese Medicine. She continued her work on the chemical composition of traditional Chinese herbs. #career #research #TCM
In response to the Vietnam War's malaria crisis, Chinese leader Mao Zedong launched Project 523, a secret military research program to find new antimalarial drugs. Tu Youyou was later assigned to this project. #malaria #research #China
Tu Youyou was appointed head of the Project 523 research team at the Academy of Traditional Chinese Medicine. She was tasked with screening traditional Chinese medicine remedies for malaria. #leadership #malaria #TCM
Tu Youyou and her team systematically screened over 2,000 herbal recipes from ancient Chinese medical texts. They identified 640 potential treatments and tested 380 extracts on malaria-infected animals. #research #herbal #malaria
Early extracts from Artemisia annua (sweet wormwood) showed inconsistent and weak antimalarial activity. Tu Youyou realized that high-temperature extraction might be destroying the active compound. #research #challenge #malaria
Using a low-temperature ether extraction method inspired by Ge Hong's text, Tu Youyou obtained a pure, stable extract (later named artemisinin) that showed 100% efficacy against malaria parasites in mice and monkeys. #breakthrough #extraction #malaria
Tu Youyou revisited the ancient text 'Emergency Prescriptions Kept Up One's Sleeve' (Zhouhou Beiji Fang) by Ge Hong (283-343 CE). She found a recipe for treating fever using Artemisia annua soaked in cold water. #ancient #TCM #discovery
Tu Youyou and her team tested the extract on 21 human malaria patients, including herself and colleagues, after animal trials. The results showed rapid fever reduction and parasite clearance. #clinical #trials #malaria
Tu Youyou successfully isolated the pure crystalline compound artemisinin (qinghaosu) from Artemisia annua. The compound's structure was later determined to be a sesquiterpene lactone with a peroxide bridge. #chemistry #isolation #malaria
Tu Youyou and her team synthesized dihydroartemisinin, a more potent derivative of artemisinin. This compound became the basis for many modern artemisinin-based combination therapies (ACTs). #chemistry #derivative #malaria
Field trials in Hainan Province, a malaria-endemic region, confirmed artemisinin's efficacy against both Plasmodium falciparum and Plasmodium vivax malaria. The drug was fast-acting and well-tolerated. #clinical #field #malaria
Collaborating with the Institute of Biophysics, Chinese Academy of Sciences, Tu Youyou's team used X-ray crystallography to determine the exact molecular structure of artemisinin, revealing its unique endoperoxide bridge. #chemistry #structure #malaria
Tu Youyou and her team published their findings on artemisinin in the Chinese Science Bulletin. The paper detailed the extraction, isolation, and clinical efficacy of qinghaosu. #publication #research #malaria
Tu Youyou received the National Invention Award from the Chinese government for her discovery of artemisinin. This was one of the highest scientific honors in China at the time. #award #recognition #China
The World Health Organization (WHO) endorsed artemisinin as a key antimalarial drug. This led to increased international collaboration and production of artemisinin-based therapies. #WHO #malaria #globalhealth
Artemisinin and its derivatives, including artemether and artesunate, were approved for clinical use in China. These drugs became the standard treatment for malaria in the country. #approval #medicine #China
Tu Youyou was promoted to professor and director of the Qinghaosu Research Center at the China Academy of Chinese Medical Sciences. She continued to lead research on artemisinin and its applications. #career #leadership #research
The WHO officially recommended artemisinin-based combination therapies (ACTs) as the first-line treatment for uncomplicated malaria. This policy shift helped combat drug resistance. #WHO #ACT #malaria
The United Nations included malaria reduction as a key target in the Millennium Development Goals. Artemisinin-based therapies played a crucial role in achieving significant reductions in malaria mortality. #UN #globalhealth #malaria
Reports of artemisinin resistance in Plasmodium falciparum emerged along the Cambodia-Thailand border. This prompted global efforts to monitor and contain resistance through combination therapies. #resistance #malaria #globalhealth
Tu Youyou was elected as an academician of the Chinese Academy of Engineering, recognizing her lifetime contributions to pharmaceutical sciences and public health. #honor #academia #China
The WHO prequalified injectable artesunate for the treatment of severe malaria. This facilitated global procurement and distribution, saving millions of lives. #WHO #severe #malaria
Large-scale production of artemisinin from Artemisia annua and semi-synthetic methods increased to meet global demand. This helped reduce costs and improve access in endemic regions. #production #access #malaria
Tu Youyou was awarded the Lasker-DeBakey Clinical Medical Research Award for her discovery of artemisinin. This prestigious award highlighted her work's impact on global health. #award #recognition #globalhealth
Tu Youyou received the Lasker Prize in New York, bringing international attention to her discovery. She donated the prize money to further research in traditional Chinese medicine. #award #international #TCM
By 2011, artemisinin-based therapies were estimated to save over one million lives each year. The drug dramatically reduced malaria mortality rates, especially in sub-Saharan Africa. #impact #lives #malaria
Tu Youyou was awarded the Nobel Prize in Physiology or Medicine for her discovery of artemisinin. She shared half of the prize with William C. Campbell and Satoshi Ōmura for their work on parasitic diseases. #Nobel #medicine #malaria
Tu Youyou delivered her Nobel Lecture titled 'Discovery of Artemisinin: A Gift from Traditional Chinese Medicine to the World' at the Nobel Assembly in Stockholm, Sweden. #Nobel #lecture #TCM
The International Astronomical Union named asteroid 31231 'Tu Youyou' in her honor. This recognition highlights her contributions to science and humanity. #asteroid #honor #science
Tu Youyou published a memoir detailing her journey in discovering artemisinin. The book provides insights into the challenges and triumphs of her research under difficult conditions. #memoir #book #research
Reports confirmed artemisinin resistance in Rwanda and other African countries. This underscored the need for new antimalarial drugs and vigilant monitoring. #resistance #Africa #malaria
Tu Youyou was awarded the 'Reform Pioneer' medal by the Chinese government for her contributions to science and healthcare reform. She was one of 100 recipients. #award #China #honor
The WHO launched a global strategy to contain artemisinin resistance, emphasizing combination therapies and vector control. Tu Youyou's work remained central to these efforts. #WHO #resistance #strategy
Tu Youyou celebrated her 90th birthday, with tributes from the scientific community and Chinese government. Her legacy as a pioneer in malaria treatment was widely recognized. #birthday #legacy #celebration
During the COVID-19 pandemic, artemisinin and its derivatives were investigated for potential antiviral effects. Preliminary studies showed some activity, but clinical efficacy remained unproven. #COVID19 #research #antiviral
Tu Youyou donated $1 million to Peking University to establish a scholarship for young researchers in traditional Chinese medicine and pharmaceutical sciences. #donation #education #TCM
The WHO reported that global malaria deaths had fallen by 95% since 2000, largely due to artemisinin-based therapies. Tu Youyou's discovery was credited as a key factor. #WHO #progress #malaria
An English-language biography of Tu Youyou, titled 'Tu Youyou: The Woman Who Saved Millions of Lives', was published, introducing her story to a global audience. #biography #book #inspiration
As of 2024, artemisinin-based combination therapies remain the WHO-recommended first-line treatment for uncomplicated malaria. Ongoing research focuses on overcoming resistance and improving delivery. #treatment #malaria #globalhealth